Skip to main content

OXERVATE

Generic: cenegermin-bkbj

Data may be stale·Apr 23, 2026
Manufacturer
Dompe
NDC
71981-001
RxCUI
2104336
ICD-10 indication
H16.29

Affordability Check

How much will you actually pay for OXERVATE?

In 30 seconds, see every legitimate way to afford OXERVATE — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About OXERVATE

What is this medication?

OXERVATE is a prescription eye drop used to treat a rare condition known as neurotrophic keratitis, which affects the health and integrity of the cornea. This disease occurs when corneal nerves are damaged, leading to a loss of sensation and an inability for the eye to heal itself from surface injuries. Without proper treatment, this can result in corneal ulcers or thinning of the eye tissue. This medication works by addressing the underlying cause of the condition to promote the healing of the corneal surface and prevent further complications.

The active component of OXERVATE is cenegermin-bkbj, a recombinant human nerve growth factor that mimics a protein found naturally in the body. This protein is essential for the survival and repair of the nerves that maintain the corneal surface. By providing this growth factor directly to the eye, the medication stimulates the regrowth of damaged nerves and epithelial cells. It is typically used for a specific duration, such as an eight-week course, to help the eye recover its protective functions and structural integrity.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How OXERVATE appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).

Covered by plans

16%

901 of 5,499 plans

Most common tier

Tier 5

On 80% of covering formularies

Prior authorization required

100%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)9
16%
Tier 2 (generic)2
4%
Tier 5 (specialty)44
80%

Step therapy: 0% of formularies

Quantity limits: 27% of formularies

Coverage breadth: 55 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

—

Medicare Part D

———

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.